Discovery of Cardioprotective Markers in Huangqi Shengmai Yin via Integrated UHPLC‐Q‐TOF‐MS/MS Fingerprinting, Chemometric Quality Assessment, and Bioactivity Correlation
Journal of Separation Science · 2026
DOI: 10.1002/jssc.70509 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Separation Science, 2026. Verfasst von Peijing Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Yongkang First People's Hospital Affiliated to Hangzhou Medical College, Yongkang, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Cardiotonic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Huangqi Shengmai Yin (HQSMY) displays notable cardioprotective properties. Nevertheless, the principal pharmacodynamic constituents underpinning this efficacy have not yet been fully clarified. To tackle this issue, an integrative workflow coupling UHPLC‑Q‑TOF‑MS/MS fingerprinting, chemometrics, and spectrum‑effect correlations was constructed for the systematic discovery of cardioprotective markers. Fifty‐one components from 10 batches of HQSMY samples were characterized by UHPLC‑Q‑TOF‑MS/MS in conjunction with the GNPS molecular networking platform. Subsequently, chromatographic fingerprints were established, with 22 and 29 characteristic common peaks assigned in negative and positive ion modes, respectively. Interbatch consistency was assessed via chemometric methods. Spectrum‑effect relationship analyses were conducted through Pearson correlation, gray relational analysis, and OPLS regression, revealing that formononetin, astrapterocarpan, astragaloside II, schisandrin, and biochanin A exhibited highly significant positive correlations with H9c2 cardiomyocyte protective activity. All these compounds attained gray relational scores exceeding 0.7, implying strong associations with cardioprotective action. These five components were then chosen from the candidate markers for subsequent functional validation using the CCK‐8 assay, which yielded EC 50 values of 18.60 ± 3.15 µM (biochanin A), 26.42 ± 4.78 µM (formononetin), 92.93 ± 19.14 µM (astragaloside II), 70.85 ± 13.26 µM (schisandrin), and 72.73 ± 14.05 µM (astrapterocarpan). The cardioprotective effect of astragaloside II, schisandrin, and astrapterocarpan in H 2 O 2 ‐induced H9c2 injury model were reported for the first time. This integrated analytical strategy not only pinpoints the primary cardioprotective components of HQSMY but also furnishes a dependable methodological framework for quality evaluation and pharmacodynamic material research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Yongkang First People's Hospital Affiliated to Hangzhou Medical College, Yongkang, China.
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, China.
ORCID-Profile: Yi Tao
Zitieren
APA
Jiang, P., Lv, Y., Zhang, J., Chen, Y., Jin, Z., Lv, X., Lv, Y., & Tao, Y. (2026). Discovery of Cardioprotective Markers in Huangqi Shengmai Yin via Integrated UHPLC‐Q‐TOF‐MS/MS Fingerprinting, Chemometric Quality Assessment, and Bioactivity Correlation. Journal of Separation Science. https://doi.org/10.1002/jssc.70509
Vancouver
Jiang P, Lv Y, Zhang J, Chen Y, Jin Z, Lv X, et al. Discovery of Cardioprotective Markers in Huangqi Shengmai Yin via Integrated UHPLC‐Q‐TOF‐MS/MS Fingerprinting, Chemometric Quality Assessment, and Bioactivity Correlation. Journal of Separation Science. 2026. doi:10.1002/jssc.70509
BibTeX
@article{Jiang2026,
author = {Jiang, Peijing and Lv, Yacheng and Zhang, Jie and Chen, Yangsheng and Jin, Zhuoying and Lv, Xiangqun and Lv, Yanxia and Tao, Yi},
title = {Discovery of Cardioprotective Markers in Huangqi Shengmai Yin via Integrated UHPLC‐Q‐TOF‐MS/MS Fingerprinting, Chemometric Quality Assessment, and Bioactivity Correlation},
journal = {Journal of Separation Science},
year = {2026},
doi = {10.1002/jssc.70509}
}
EUVIMED